Trusted by nursing and midwifery students and clinicians in Australia since 1983, the 11th edition of Havard’s Nursing Guide to Drugs is an indispensable tool for reliable, accurate and up-to-date drug information. The guide is easy to access and user-friendly. It provides all the medication information you need to know, with drugs classified by both therapeutic class and body system, and referred to by both trade and generic name. The book includes best practice in drug administration as well as patient teaching information to improve care. This edition has been comprehensively reviewed and updated to ensure that usage, dose, side effects, contraindications and precautions are consistent with current Australian pharmaceutical guidelines.
1. Introduction - p. x 2. Reviewers - p. xxxiii 3. Acne treatment - p. 1 4. Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) - p. 11 5. Anorectics and weight-loss agents - p. 37 6. Anthelmintics - p. 44 7. Anti-Alzheimer’s agents - p. 53 8. Antianginal agents - p. 60 9. Antianxiety agents - p. 73 10. Antiarrhythmic agents - p. 81 11. Antiasthma agents, bronchodilators and respiratory agents - p. 95 12. Antibacterial agents - p. 146 13. INHIBITORS OF BACTERIAL CELL WALL SYNTHESIS - p. 150 14. PENICILLINS - p. 150 15. CEPHALOSPORINS - p. 164 16. MONOBACTAMS AND CARBAPENEMS - p. 176 17. GLYCOPEPTIDES - p. 180 18. INHIBITORS OF BACTERIAL PROTEIN SYNTHESIS - p. 184 19. AMINOGLYCOSIDES - p. 184 20. TETRACYCLINES - p. 192 21. MACROLIDES - p. 196 22. LINCOSAMIDES - p. 203 23. OTHER MISCELLANEOUS INHIBITORS OF BACTERIAL PROTEIN SYNTHESIS - p. 207 24. INHIBITORS OF DNA SYNTHESIS - p. 212 25. QUINOLONES (ALSO KNOWN AS FLUOROQUINOLONES) - p. 212 26. DISRUPTING BACTERIAL CELL MEMBRANE - p. 218 27. OTHER ANTIBACTERIAL AGENTS - p. 220 28. Anticoagulants and antithrombotic agents - p. 233 29. Antidepressants - p. 262 30. Antidiabetic agents - p. 294 31. Antidiarrhoeal agents - p. 328 32. Antidotes, antagonists and chelating agents - p. 332 33. Antiemetic agents - p. 365 34. Antiepileptics - p. 381 35. Antifungal agents - p. 420 36. Antiglaucoma agents - p. 452 37. Antigout and uricolytic agents - p. 465 38. Antihistamines - p. 474 39. Antihypertensive agents - p. 488 40. ALPHA-ADRENOCEPTOR BLOCKING AGENTS - p. 490 41. ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS - p. 493 42. ANGIOTENSIN II RECEPTOR ANTAGONISTS - p. 502 43. BETA-ADRENOCEPTOR BLOCKING AGENTS - p. 508 44. CALCIUM-CHANNEL BLOCKERS - p. 519 45. CENTRALLY ACTING AGENTS - p. 530 46. DIRECT ACTING VASODILATORS - p. 535 47. Antimalarial agents - p. 542 48. Antimigraine agents - p. 555 49. Antimycobacterial agents - p. 567 50. Antineoplastic agents - p. 581 51. Antineoplastic support agents - p. 715 52. Anti-Parkinson’s agents - p. 729 53. Antiplatelet agents - p. 753 54. Antiprotozoal agents - p. 763 55. Antipsychotic and mood-stabilising agents - p. 771 56. Antiulcer agents - p. 805 57. Antiviral agents - p. 823 58. ANTIVIRAL (NON-RETROVIRAL) AGENTS - p. 824 59. DNA POLYMERASE INHIBITORS - p. 824 60. NEURAMINIDASE INHIBITORS - p. 836 61. NS3/4A PROTEASE INHIBITORS - p. 838 62. NS5A INHIBITORS - p. 838 63. NS5B RNA-DEPENDENT RNA PROTEASE INHIBITORS - p. 839 64. OTHER ANTIVIRAL AGENTS - p. 841 65. ANTIRETROVIRAL AGENTS - p. 845 66. NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIs) - p. 848 67. NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIs) - p. 853 68. PROTEASE INHIBITORS (PI) - p. 857 69. ENTRY INHIBITORS - p. 866 70. INTEGRASE INHIBITORS - p. 868 71. Bladder function disorder agents - p. 870 72. Bone and calcium regulating agents - p. 885 73. Cardiac glycosides - p. 906 74. Cholinergic and anticholinergic agents - p. 912 75. Corticosteroids - p. 922 76. Cough suppressants and expectorants - p. 948 77. Dermatological agents - p. 954 78. Disease-modifying antirheumatic drugs (DMARDs) - p. 970 79. Diuretics - p. 1010 80. Drug dependence - p. 1034 81. Erectile dysfunction agents - p. 1049 82. Eye, ear, nose and throat agents - p. 1062 83. Fibrinolytic agents - p. 1087 84. Gastrointestinal agents (miscellaneous) - p. 1093 85. General anaesthetics - p. 1107 86. Haemopoietic agents - p. 1118 87. Haemostatics - p. 1128 88. Hypothalamic and pituitary hormones - p. 1151 89. Immunomodifiers - p. 1176 90. INTERFERONS - p. 1222 91. Laxatives - p. 1229 92. Lipid regulating agents - p. 1244 93. Local anaesthetics - p. 1264 94. Metabolic disorders agents - p. 1278 95. Movement disorder agents - p. 1309 96. Muscle relaxants - p. 1337 97. Neuromuscular blocking agents - p. 1353 98. Opioid analgesics - p. 1363 99. Pregnancy, childbirth and breastfeeding - p. 1389 100. Pulmonary hypertension agents - p. 1424 101. Sedatives and hypnotics - p. 1434 102. Sex hormones - p. 1448 103. Stimulants - p. 1485 104. Sympathomimetic agents - p. 1499 105. Thyroid and antithyroid agents - p. 1513 106. Vaccines, immunoglobulins and antivenoms - p. 1524 107. Vasodilators - p. 1569 108. Vitamins, minerals and electrolytes - p. 1573 109. Miscellaneous agents - p. 1609 110. Appendix 1 Poisoning and its treatment - p. 1618 111. Appendix 2 Poisons information centres - p. 1623 112. Appendix 3 Changes to drug names - p. 1624 113. Bibliography - p. 1626 114. Glossary - p. 1638 115. Index - p. 1645 116. Inside back cover - p. 1738 117. Common abbreviations - p. ES4
Trusted by nursing and midwifery students and clinicians in Australia since 1983, the 11th edition of Havard’s Nursing Guide to Drugs is an indispensable tool for reliable, accurate and up-to-date drug information. The guide is easy to access and user-friendly. It provides all the medication information you need to know, with drugs classified by both therapeutic class and body system, and referred to by both trade and generic name. The book includes best practice in drug administration as well as patient teaching information to improve care. This edition has been comprehensively reviewed and updated to ensure that usage, dose, side effects, contraindications and precautions are consistent with current Australian pharmaceutical guidelines.
1. Introduction - p. x 2. Reviewers - p. xxxiii 3. Acne treatment - p. 1 4. Analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) - p. 11 5. Anorectics and weight-loss agents - p. 37 6. Anthelmintics - p. 44 7. Anti-Alzheimer’s agents - p. 53 8. Antianginal agents - p. 60 9. Antianxiety agents - p. 73 10. Antiarrhythmic agents - p. 81 11. Antiasthma agents, bronchodilators and respiratory agents - p. 95 12. Antibacterial agents - p. 146 13. INHIBITORS OF BACTERIAL CELL WALL SYNTHESIS - p. 150 14. PENICILLINS - p. 150 15. CEPHALOSPORINS - p. 164 16. MONOBACTAMS AND CARBAPENEMS - p. 176 17. GLYCOPEPTIDES - p. 180 18. INHIBITORS OF BACTERIAL PROTEIN SYNTHESIS - p. 184 19. AMINOGLYCOSIDES - p. 184 20. TETRACYCLINES - p. 192 21. MACROLIDES - p. 196 22. LINCOSAMIDES - p. 203 23. OTHER MISCELLANEOUS INHIBITORS OF BACTERIAL PROTEIN SYNTHESIS - p. 207 24. INHIBITORS OF DNA SYNTHESIS - p. 212 25. QUINOLONES (ALSO KNOWN AS FLUOROQUINOLONES) - p. 212 26. DISRUPTING BACTERIAL CELL MEMBRANE - p. 218 27. OTHER ANTIBACTERIAL AGENTS - p. 220 28. Anticoagulants and antithrombotic agents - p. 233 29. Antidepressants - p. 262 30. Antidiabetic agents - p. 294 31. Antidiarrhoeal agents - p. 328 32. Antidotes, antagonists and chelating agents - p. 332 33. Antiemetic agents - p. 365 34. Antiepileptics - p. 381 35. Antifungal agents - p. 420 36. Antiglaucoma agents - p. 452 37. Antigout and uricolytic agents - p. 465 38. Antihistamines - p. 474 39. Antihypertensive agents - p. 488 40. ALPHA-ADRENOCEPTOR BLOCKING AGENTS - p. 490 41. ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS - p. 493 42. ANGIOTENSIN II RECEPTOR ANTAGONISTS - p. 502 43. BETA-ADRENOCEPTOR BLOCKING AGENTS - p. 508 44. CALCIUM-CHANNEL BLOCKERS - p. 519 45. CENTRALLY ACTING AGENTS - p. 530 46. DIRECT ACTING VASODILATORS - p. 535 47. Antimalarial agents - p. 542 48. Antimigraine agents - p. 555 49. Antimycobacterial agents - p. 567 50. Antineoplastic agents - p. 581 51. Antineoplastic support agents - p. 715 52. Anti-Parkinson’s agents - p. 729 53. Antiplatelet agents - p. 753 54. Antiprotozoal agents - p. 763 55. Antipsychotic and mood-stabilising agents - p. 771 56. Antiulcer agents - p. 805 57. Antiviral agents - p. 823 58. ANTIVIRAL (NON-RETROVIRAL) AGENTS - p. 824 59. DNA POLYMERASE INHIBITORS - p. 824 60. NEURAMINIDASE INHIBITORS - p. 836 61. NS3/4A PROTEASE INHIBITORS - p. 838 62. NS5A INHIBITORS - p. 838 63. NS5B RNA-DEPENDENT RNA PROTEASE INHIBITORS - p. 839 64. OTHER ANTIVIRAL AGENTS - p. 841 65. ANTIRETROVIRAL AGENTS - p. 845 66. NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIs) - p. 848 67. NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIs) - p. 853 68. PROTEASE INHIBITORS (PI) - p. 857 69. ENTRY INHIBITORS - p. 866 70. INTEGRASE INHIBITORS - p. 868 71. Bladder function disorder agents - p. 870 72. Bone and calcium regulating agents - p. 885 73. Cardiac glycosides - p. 906 74. Cholinergic and anticholinergic agents - p. 912 75. Corticosteroids - p. 922 76. Cough suppressants and expectorants - p. 948 77. Dermatological agents - p. 954 78. Disease-modifying antirheumatic drugs (DMARDs) - p. 970 79. Diuretics - p. 1010 80. Drug dependence - p. 1034 81. Erectile dysfunction agents - p. 1049 82. Eye, ear, nose and throat agents - p. 1062 83. Fibrinolytic agents - p. 1087 84. Gastrointestinal agents (miscellaneous) - p. 1093 85. General anaesthetics - p. 1107 86. Haemopoietic agents - p. 1118 87. Haemostatics - p. 1128 88. Hypothalamic and pituitary hormones - p. 1151 89. Immunomodifiers - p. 1176 90. INTERFERONS - p. 1222 91. Laxatives - p. 1229 92. Lipid regulating agents - p. 1244 93. Local anaesthetics - p. 1264 94. Metabolic disorders agents - p. 1278 95. Movement disorder agents - p. 1309 96. Muscle relaxants - p. 1337 97. Neuromuscular blocking agents - p. 1353 98. Opioid analgesics - p. 1363 99. Pregnancy, childbirth and breastfeeding - p. 1389 100. Pulmonary hypertension agents - p. 1424 101. Sedatives and hypnotics - p. 1434 102. Sex hormones - p. 1448 103. Stimulants - p. 1485 104. Sympathomimetic agents - p. 1499 105. Thyroid and antithyroid agents - p. 1513 106. Vaccines, immunoglobulins and antivenoms - p. 1524 107. Vasodilators - p. 1569 108. Vitamins, minerals and electrolytes - p. 1573 109. Miscellaneous agents - p. 1609 110. Appendix 1 Poisoning and its treatment - p. 1618 111. Appendix 2 Poisons information centres - p. 1623 112. Appendix 3 Changes to drug names - p. 1624 113. Bibliography - p. 1626 114. Glossary - p. 1638 115. Index - p. 1645 116. Inside back cover - p. 1738 117. Common abbreviations - p. ES4
